Health ❯ Healthcare ❯ Pharmacy

Medication

Supply Issues Government Regulation Hay Fever Treatments Prescription Medicines Patient Safety Weight Loss Consultation with Healthcare Professionals Aspirin Supply Chain Indigestion Remedies Patient Education Weight Management Emergency Services Over-the-Counter Medications Patient Care Drug Shortage Dehydration Risks Heatwave Effects Shortages Side Effects Co-codamol Temperature Sensitivity Repeat Prescriptions IMCIVREE Hay Fever Drug Stability Alternative Treatments

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

The decision follows a late-stage study that showed a 15.8% BMI reduction at 52 weeks compared with a 2.6% increase on placebo.

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.